Skip to main content

Rhythm Pharmaceuticals, Inc.

RYTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001649904

In the last 90 days, Rhythm Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $8.55B in total; Duquesne Family Office is the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Rhythm Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of RYTM: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders10597−8
Shares47.5M48.0M+470.2K (+1.0%)
Value$905.6M$626.3M−$279.3M (−30.8%)

New holders (7)

Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to RYTM in Q3 2021
InstitutionSharesValue% of portfolio
Franklin Resources Inc168,083$2.19M0.00%
Walleye Capital LLC49,845$651.0K0.02%
AQR Capital Management LLC10,191$133.0K0.00%
Hantz Financial Services, Inc.5,883$77.0K0.00%
Koshinski Asset Management, Inc.1,060$13.8K0.00%
FourThought Financial, LLC570$7.00K0.00%
Parallel Advisors, LLC181$2.00K0.00%

Sold out (15)

Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of RYTM in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Bank of Montreal151,446$3.09M
Altium Capital Management LP104,840$2.05M
Caas Capital Management LP84,044$1.65M
Renaissance Technologies LLC52,200$1.02M
Ensign Peak Advisors, Inc40,891$801.0K
Brandywine Global Investment Management, LLC40,663$796.0K
Citadel Advisors LLC32,574$638.0K
Squarepoint Ops LLC20,611$404.0K
Principal Financial Group Inc11,364$223.0K
Cutler Group LP7,418$145.0K
Meeder Asset Management Inc6,078$119.0K
Exane Derivatives5,167$100.1K
Retirement Group, LLC3,812$75.0K
FORA Capital, LLC1,085$21.0K
Berman Capital Advisors, LLC42$0